Adipokines, Inflammation, and Metabolic Diseases
141 ta ish
2-TUR QANDLI DIABET: DOLZARBLIGI, RIVOJLANISHI, SABABLARI VA OLDINI OLISH YOʻLLARI
Toshpo'latova Sevinch Jamshid qizi, Kibriyev Bexruz Abduraxmonovich, Kattaboyeva Muhayyo Nurmuhammad qizi
MaqolaEducation, Innovation and Language StudiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABI2-TUR QANDLI DIABET: DOLZARBLIGI, RIVOJLANISHI, SABABLARI VA OLDINI OLISH YOʻLLARI
Toshpo'latova Sevinch Jamshid qizi, Kibriyev Bexruz Abduraxmonovich, Kattaboyeva Muhayyo Nurmuhammad qizi
MaqolaEducation, Innovation and Language StudiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABITAJRIBAVIY QANDLI DIABETDA PESTITSIDLAR BILAN SURUNKALI 9 OY ZAXARLANGANDA KALAMUSHLAR OSHQOZON OSTI BEZIDA YUZAGA KELADIGAN MORFOLOGIK OʻZGARISHLAR
Xabibulla Pulatov, Abbosxoʻja Ubaydullayev
MaqolaToxin Mechanisms and ImmunotoxinsZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABITAJRIBAVIY QANDLI DIABETDA PESTITSIDLAR BILAN SURUNKALI 9 OY ZAXARLANGANDA KALAMUSHLAR OSHQOZON OSTI BEZIDA YUZAGA KELADIGAN MORFOLOGIK OʻZGARISHLAR
Xabibulla Pulatov, Abbosxoʻja Ubaydullayev
MaqolaToxin Mechanisms and ImmunotoxinsZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABITYPE 2 DIABETES MELLITUS: GLOBAL EPIDEMIOLOGICAL TRENDS, MOLECULAR MECHANISMS AND RISK FACTORS WITH SPECIAL REFERENCE TO UZBEKISTAN
D.R. Pazliddinova, I.R. Nusratullayev, A.V. Pazliddinov
MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABI